Measurement of clinical outcomes of Netherton syndrome following treatment with upadacitinib
The Journal of Dermatology · 2024-11 · 51 (11)
DOI: 10.1111/1346-8138.17319 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Journal of Dermatology, online erschienen am 07.06.2024. Verfasst von Chiaki Murase und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: Ministry of Health, Labour and Welfare, Japan Science and Technology Agency, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
- Department of Dermatology, Toyota Memorial Hospital, Toyota, Aichi, Japan.
- Department of Paediatrics, Toyota Memorial Hospital, Toyota, Aichi, Japan.
ORCID-Profile: Chiaki Murase, Ryo Fukaura, Tomoki Taki, Takuya Takeichi, Masashi Akiyama
Förderung
- Ministry of Health, Labour and Welfare
- Japan Science and Technology Agency
- Japan Society for the Promotion of Science
Zitieren
APA
Murase, C., Fukaura, R., Yamada, N., Konishi-Izuchi, N., Adachi, H., Taki, T., Hara, S., Takeichi, T., & Akiyama, M. (2024). Measurement of clinical outcomes of Netherton syndrome following treatment with upadacitinib. The Journal of Dermatology, 51(11). https://doi.org/10.1111/1346-8138.17319
Vancouver
Murase C, Fukaura R, Yamada N, Konishi-Izuchi N, Adachi H, Taki T, et al. Measurement of clinical outcomes of Netherton syndrome following treatment with upadacitinib. The Journal of Dermatology. 2024;51(11). doi:10.1111/1346-8138.17319
BibTeX
@article{Murase2024,
author = {Murase, Chiaki and Fukaura, Ryo and Yamada, Naoto and Konishi-Izuchi, Natsuno and Adachi, Hidesada and Taki, Tomoki and Hara, Shinya and Takeichi, Takuya and Akiyama, Masashi},
title = {Measurement of clinical outcomes of Netherton syndrome following treatment with upadacitinib},
journal = {The Journal of Dermatology},
year = {2024},
volume = {51},
number = {11},
doi = {10.1111/1346-8138.17319}
}
EUVIMED